The cardiorenal syndrome in diabetes mellitus

Area of Science:

• Cardiorenal medicine
• Diabetology
• Nephrology
• Cardiology

Background:

• Diabetes mellitus is a major risk factor for cardiovascular disease (CVD) and diabetic nephropathy.
• Cardiorenal syndrome in diabetes involves systemic effects on both cardiovascular and renal systems.
• Pathogenesis includes TGF-beta and VEGF systems, hemodynamic forces, metabolic factors, and oxidative stress.

Purpose of the Study:

• To explore the cardiorenal syndrome in diabetic patients.
• To understand the multifactorial pathogenesis of CVD and nephropathy in diabetes.
• To evaluate the impact of intensified interventions on renal and cardiovascular outcomes.

Main Methods:

• Review of existing literature on cardiorenal syndrome in diabetes mellitus.
• Analysis of the roles of specific molecular pathways (e.g., TGF-beta, VEGF).
• Examination of multifactorial contributors to cardiovascular disease pathogenesis in diabetes.

Main Results:

• Intensive glycemic control reduces microvascular complications in diabetes but has less clear cardiovascular benefits.
• Managing hypertension, dyslipidemia, and the renin-angiotensin-aldosterone system in type 2 diabetes significantly reduces renal disease progression.
• These intensified interventions are paralleled by a significant reduction in cardiovascular disease burden.

Conclusions:

• Cardiorenal syndrome in diabetes is a complex systemic condition requiring multifaceted management.
• Targeting CVD risk factors alongside glycemic control is crucial for mitigating both renal and cardiovascular complications in diabetic patients.
• Interventions addressing hypertension, dyslipidemia, and the renin-angiotensin-aldosterone system show promise in reducing cardiorenal burden.